FDA official discusses common deficiencies derailing ANDAs
Regulatory NewsJoanne S. Eglovitch
ComplianceFDA meeting and communication strategyNorth AmericaPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/PolicyRegulatory NewsJoanne S. EglovitchComplianceFDA meeting and communication strategyNorth AmericaPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/Policy